Aerion Bioscience is a startup based in France, 1 tracked investor.
Aerion Bioscience is a startup founded in 2021 based in France. Brouky records 1 investor associated with the company.
Aerion Bioscience develops a blood-based cancer screening technology for early detection of lung cancer through non-invasive diagnostic testing, using plasma-based biomarker analysis and proprietary protein panels.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.